ID: ALA1159890

Max Phase: Preclinical

Molecular Formula: C15H21NO3

Molecular Weight: 263.34

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C#CCOc1ccccc1OCC(O)CNC(C)C

Standard InChI:  InChI=1S/C15H21NO3/c1-4-9-18-14-7-5-6-8-15(14)19-11-13(17)10-16-12(2)3/h1,5-8,12-13,16-17H,9-11H2,2-3H3

Standard InChI Key:  FYOGTFROMBUNKU-UHFFFAOYSA-N

Associated Targets(non-human)

Beta-2 adrenergic receptor 182 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 263.34Molecular Weight (Monoisotopic): 263.1521AlogP: 1.44#Rotatable Bonds: 8
Polar Surface Area: 50.72Molecular Species: BASEHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.67CX LogP: 1.66CX LogD: -0.56
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.70Np Likeness Score: -0.77

References

1. IJzerman AP, Aué GH, Bultsma T, Linschoten MR, Timmerman H..  (1985)  Quantitative evaluation of the beta 2-adrenoceptor affinity of phenoxypropanolamines and phenylethanolamines.,  28  (9): [PMID:2993621] [10.1021/jm00147a037]

Source